Virological and histological outcome of a patient with chronic hepatitis B transplanted with liver from hepatitis C virus-positive donor.
Chan
H L Y
HL
Departments of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Chui
A K K
AK
Chan
F K L
FK
Rao
A R N
AR
Wong
J
J
Lau
W-Y
WY
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D002102:Cadaver; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy; D006513:Hepatitis B e Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000302:isolation & purification; D019694:Hepatitis B, Chronic / Q000150:complications / Q000601:surgery*; D006526:Hepatitis C / Q000517:prevention & control / Q000635:transmission*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000601:surgery* / Q000821:virology; D008113:Liver Neoplasms / Q000150:complications / Q000188:drug therapy; D008297:Male; D014019:Tissue Donors
D000998:Antiviral Agents; D006513:Hepatitis B e Antigens; D019259:Lamivudine